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TGFb2Abstract The present study was conducted to evaluate the effect of caffeine and retinoic acid either
separately or in combination on the skeleton of the developing embryos of mice. Pregnant females
were treated with either caffeine or retinoic acid at the onset of organogenesis (7th day of gestation).
At morphological level no abnormalities in either caffeine or retinoic acid in the developing
embryos at 14th day of gestation whose mothers’ were administered caffeine (2 mg/100 g b.w.) or
those of the mothers’ treated with retinoic acid up to 4 mg/kg b.w. during the onset of the second
trimester of pregnancy were observed. However, dose-dependent retinoic acid treatment initiates
chondrocyte vacuolation, depression of PAS+ve intracellular inclusions and depression of nuclear
fluorescence that were concomitant with downregulation of TGFb2 expression in the perichon-
drium of the developing vertebrae. Co-administration of caffeine was found to ameliorate the
effects of 2 mg/kg b.w. rather than 4 mg/kg b.w. of retinoic acid treatment. At the 18th day of ges-
tation the uterine horns appeared normal without any signs of fetoresorption in all treatments.
However, the effect of both caffeine (2 mg/100 g b.w) and retinoic acid at both doses (2, 4 mg/kg
b.w) in Alizarin Red stain of wholemount revealed minor phalange deformation of the developing
limbs either separately or in combined treatments.
 2016 The Egyptian German Society for Zoology. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The increasing popularity of caffeine-containing energy drinks
(Mintel International, 2008), along with a variety of newly mar-
keted caffeinated products contribute in higher caffeine intake
during pregnancy. One of the prenatal exposures examined
for association with preterm birth has been caffeine consump-
tion. Caffeine (1,3,7-trimethylxanthine), a plant alkaloid found
in coffee, tea, cocoa, and cola soft drinks, is one of the most fre-quently consumed substances (Nawrot et al., 2003). 1994–1996
survey found that 68% of pregnant women consumed caffeine
in US, with an average intake of 125 mg (approximately equiv-
alent to 1.25 cups of coffee) per day (Frary et al., 2005). A study
suggests an increased risk of growth restriction, cardiovascular
abnormalities, and skeletal abnormalities in children of women
with high caffeine intake during pregnancy (Golding, 1995).
Caffeine easily crosses the placenta and is known to decrease
placental blood flow, fetal heart rate and has been detected in
uterine secretions and amniotic fluid (Kirkinen et al., 1983;
Mose et al., 2008). During pregnancy, the rate of caffeine meta-
bolism decreases progressively from the first to third trimester,
with a doubling of the half-life of caffeine. Delayed clearance
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life of caffeine in neonates than in adults was known (Aldridge
et al., 1979; Soyka, 1981). Whether maternal caffeine intake
during pregnancy is associated with preterm birth has been
examined during the past 30 y with inconsistent results
(Nawrot et al., 2003; Pacheco et al., 2007). Results of epidemi-
ologic studies investigating caffeine teratogenicity have been
mixed; however, relatively few have examined exposure from
all major sources of caffeine in association with specific types
of birth defects. No statistically significant associations with
maternal dietary caffeine intake were observed for congenital
heart defects (Browne et al., 2007), orofacial clefts (Collier
et al., 2009), or bilateral renal agenesis or hypoplasia (Slickers
et al., 2008). Moreover, caffeine has the potential to interact
with many other exposures. For example, smoking is known
to increase the rate of caffeine metabolism in humans (Landi
et al., 1999). In rodents and chicken embryos, caffeine enhanced
teratogenicity of substances such as nicotine, alcohol,
bronchodilators, and anti-seizure medications (Nehlig and
Debry, 1994).
In addition, retinoic acid (RA) is known to plays a key role
in pattern formation during vertebrate development. It has
long been known that retinol (vitamin A) is essential for nor-
mal growth, vision, reproduction, maintenance of numerous
tissues, and overall survival of embryos (Lohnes et al., 1994;
Niederreither et al., 1996). Retinoic acid (RA), which exists
in both cis and trans isomeric forms, is the most biologically
active metabolite of vitamin A and is also essential for normal
development (Abu-Abed et al., 2002). Several studies indicated
that in utero exposure to excessive retinoic acid during preg-
nancy generates different congenital malformations (Lofberg
et al., 1990; Niederreither et al., 1996; Mulder et al., 2000;
Amini et al., 2005; Quemelo et al., 2007). These studies used
isomeric forms of retinoic acid at high dose at early stages dur-
ing embryonic development. Hence, the present study was con-
ducted to evaluate the effect of caffeine, retinoic acid and their
interaction during co-exposure at lowest doses on the skeleton
of the developing embryos of mice, Mus musculus, for their
wide uses of therapeutic purposes.Plate 1 Photographs of embryos at E14 of gestation
representing the growth morphology of control (A), caffeine (B)
and 4 mg/kg b.w. retinoic acid (C) treatments. No malformations
were recorded. Scale bar 1 cm.Materials and methods
Caffeine
Caffeine, anhydrous pure crystals (Merck, C5H10N4O2,
194.2 g/mol) was obtained commercially. Stock solution in
saline was prepared and renewed as required during the
experimental period.
Retinoic acid
Retinoic acid (C20H28O2, 300.4 g/mol) in the form of 13-cis
form (Isotretinoin) product of Sigma 500 mg/package was
obtained. In olive oil, stock solution was prepared and
renewed as required during the experimental period.
Animals and experimental design
Immature mice, Mus musculus, after weaning were obtained
from animal house of Assiut University. Animals wereacclimatized in laboratory under normal light and temperature
conditions with free access of food and water. Males and
females were kept separately till maturity in cages. For the pre-
natal study at days 14, 18 of pregnancy, one male was mixed
with two females in several cages. After the insurance of
vaginal plug following copulation in one round of gestation,
the pregnant females were classified into six groups from the
7th day of gestation (the first day of the organogenesis period
in mice) (Stro¨mland et al., 1991), G1 a control, G2
administered orally with caffeine at dose (2 mg/100 g b.w.),
G3, G4 intraperitonally injected with retinoic acid at doses 2,
4 mg/kg b.w., respectively. G5, G6 a combined groups
caffeine-administered at morning (2 mg/100 g b.w.) and at
evening intraperitonally injected with retinoic acid
(2, 4 mg/kg b.w.), respectively. Caffeine dosing of pregnant
females was carried out according to Reis et al. (2014) for
prenatal exposure of rat embryos. Meanwhile, Vitamin A
(Isotretinoin) dosing was carried out at 2, 4 mg/kg b.w., a
range of low doses that induce different abnormalities on
injected presomite of mouse embryos (Sulik et al., 1995).
Treatment of pregnant females with caffeine was conducted
daily, while retinoic acid treatment was conducted at day after
the other day for either the separate or combined treatments
from the 7th to the 18th day of gestation. Pregnant females
at day 14 and at day 18 of pregnancy for different groups were
dissected. The uterine horns and the embryos of repeated
patches of the different experimental groups were examined
morphologically. Embryos of 14 days old were fixed in
Carnoy’s fixatives for histological, histochemical and immuno-
histochemical investigations of the developing vertebrae, while
the embryos at day 18 of gestation were stored in 95% ethanol
for skeleton staining.
Histological and histochemical study
Embryos at E14 of gestation were fixed in Carnoy’s fixative,
dehydrated in ethyl alcohol, cleared in methyl benzoate and
processed for sectioning. Serial sections of embryos 7l thick
in paraffin were mounted on glass slides and dried at 40 C
38 F.E.-D.M. Lashein et al.in an oven for 3 days. Sections were stained with Hematoxylin
and Eosin for general histological picture, Periodic acid
Schiff’s (PAS) reaction for polysaccharide detection (Drury
and Wallington, 1976), and Acridin orange/Ethidium bromide
stain for nuclear fluorescence (Kasibhatla et al., 2006). In addi-
tion, alcohol-fixed 18-day whole embryos of different groups
were stained with Alizarin Red S for skeleton visualization.
Sections were dehydrated in ascending grades of ethanol,
cleared in xylene and mounted with DPX mounting media.
Selected sections of the developing vertebrae at 14th day of
gestation and 18 days of whole Alizarin Red S-stained
embryos were photographed and processed as required.
Immunohistochemistry of transforming growth factor b2
In immunohistochemical study, deparaffinized Superfrost/Plus
slide-mounted sections of embryos at 14th day of gestation of
the different experimental groups were retrieved for
re-antigenicity using 10 mM citrate buffer at pH6 in 100 C
for an hour (Buchlowalow and Bocker, 2010). After cooling
at room temperature, sections were treated for 10 min with
0.3% hydrogen peroxide block and then with protein block
(phosphate buffer solution, pH 7.6, with 0.5% BSA, 0.5%
casein and less than 0.1% sodium azide) for 10 min to block
nonspecific background staining, then sections were incubated
with primary antibody (Rabbit Anti-human TGF b2Plate 2 Photomicrographs of histological sections through the develo
acid 2, 4 mg/kg b.w. (C, D) and the combined treatments with caffeinpolyclonal antibody, Spring Bioscience, USA) washed using
phosphate buffer and incubated with secondary antibody,
Biotinylated Goat Antipolyvalent (Anti-polyvalent HRP
DAB detection system, Spring Bioscience, USA) according
to the manufacture protocol. Reactions and color were visual-
ized by using chromogene mixed with 3,30-diaminobenzidin
(1:10) (DAB substrate, chromogen, Spring Bioscience). In all
cases, negative control sections in which the primary antibody
was not applied to tissue sections were carried out. Sections
were dehydrated in ascending grades of ethanol, cleared in
xylene and mounted with DPX mounting media. Sections were
examined microscopically to evaluate the effect of caffeine,
retinoic acid and the co-administration of both in experimental
groups compared to the control. Selected sections of the devel-
oping vertebrae and whole Alizarin Red S-stained embryos
were photographed and processed as required.
Results
14 days-old embryos
Morphological examination of the developing embryos at day
14 of gestation did not reveal any abnormalities in either the
embryos whose mothers’ were administered caffeine or those
of the mother’s treated with retinoic acid even at the higher
dose of 4 mg/kg b.w.. The growth morphology of theping vertebral centrae at E 14 of control (A); caffeine (B); retinoic
e and retinoic acid (E, F). H & E stain. Scale bar 20 lm.
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Head, trunk, limbs and tail are well developed in caffeine treat-
ment (Plate 1B). In retinoic acid treatments the characteristic
malformations, omphalocele, gastroschisis, lower limb defects,
imperforated anus and tail agenesis of retinoic acid treatment
are not detected (Plate 1C). Histological examination of the
developing cartilaginous skeleton of the vertebral centrae of
the control, caffeine, retinoic acid at doses of 2, 4 mg and
the combined groups that were treated with caffeine and the
two doses of retinoic acid revealed the dose-dependent effect
of retinoic acid on the chondrocyte vacuolation and their
abundance (Plate 2C and D, respectively) in the background
of the homogenous matrix as compared to both the control
and caffeine treated embryos (Plate 2A and B) in which the
chondrocytes are dense and uniformly distributed in its back-
ground matrix. In combined treatments with caffeine, severely
vacuolated condrocytes were noted in 4 mg dose (Plate 2F)
compared to 2 mg dose (Plate 2E) and those treated with reti-
noic acid at 2 mg dose only (Plate 2C). PAS-stained sections of
cartilaginous substance revealed positive intracellular
inclusions of the developing chondrocytes of control
(Plate 3A) and those of caffeine treated (Plate 3B). In retinoic
acid treatments, either with 2 mg/kg b.w (Plate 3C) or with
4 mg/kg b.w (Plate 3D), adose-dependent decrease in which
faintly-stained PAS-positive intracellular inclusions werePlate 3 Photomicrographs of PAS-stained sections through the de
decrease in PAS-positive inclusions of chondrocytes in retinoic acid 2
upregulated in combined treatments with caffeine (E, F). PAS stain Sobserved was compared with either the control or caffeine
treatment. Caffeine was also found to exert a counter effect
on retinoic acid by upregulating the intensity of the intracellu-
lar inclusions in combined treatment at 2 mg/kg dose
(Plate 3E) rather than those treated with 4 mg (Plate 3F). In
acridin orange/ethedium bromide stained sections, chondro-
cytes with their inclusions and a network of extracellular
matrix are sharply acridinophilic that well sharply fluorescent
in control (Plate 4A). Slight inhibition of fluorescence among
the extracellular network was observed in caffeine treatment
(Plate 4B), while retinoic acid at low dose (2 mg/kg b.w) results
in darkness of the central regions of the nuclei due to the incor-
poration of ethedium bromide (Plate 4C) as compared to both
the control and caffeine treatment. In addition to the inhibited
fluorescence of the nuclei of the developing cartilage, the
extracellular network that represents the limits of the differen-
tiated lacunae was not observed in retinoic acid treatment.
Recovered lacunar limits with slight inhibition of the nuclear
fluorescence reflect the mitigating effect of caffeine on the
alterations induced by retinoic acid (Plate 4D). Immuno-
stained sections of the developing cartilage revealed a slight
downregulating effect of caffeine (Plate 5B), dose-dependent
in retinoic acid treatments (Plate 5C and D) downregulation
in the combined treatment at 2 mg/kg (Plate 5E) that inhibited
completely at 4 mg/kg of retinoic acid treatment with caffeineveloping vertebral centrae at E 14 showing the dose-dependent
, 4 mg/kg b.w. (C, D) compared to control (A), caffeine (B) that
cale bar 20 lm, 10 lm for the inserts.
Plate 4 Photomicrographs of acridin orange/ethedium bromide-
stained sections of control (A), caffeine and retinoic acid (2 mg/kg
b.w.) treatments (B, C). Counter action of caffeine on retinoic acid
is shown (D) in combined treatment. Acridin orange/ethedium
bromide stain. Scale bar 20 lm.
40 F.E.-D.M. Lashein et al.(Plate 5F) as compared to control (Plate 5 A). In all treatments
and in control the expression of TGFb2 was restricted to the
perichondrial connective tissue rather than the developing
chondrocytes.
18 days-old embryos
The growth morphology of the uterine horns containing the
developing foeti was not affected in either caffeine or retinoic
acid treatments. Embryo resorption was not observed in either
caffeine, retinoic acid or in combined treatments with both
(Plate 6). Alizarin Red-S staining of whole embryos revealed
a well developed skeleton of the major components (skull,
limbs. . .. . .etc) (Plate 7A–F), on magnifying the skeleton of
the most distal parts of the limbs (hand and foot). It was obvi-
ous that the effect of both caffeine and retinoic acid in both
doses is best manifested in the skeleton of the foot rather than
in the skeleton of the hand. Metacarpals and the skeleton of
phalanges are well developed in caffeine treated embryos
(Plate 8B) as compared to control (Plate 8A). Dose-dependent
effect of retinoic acid was noted. Missing of the second row
of the skeleton of phalanges was noted in 4 mg/kg
b.w-treated embryos (Plate 8D) as compared to those of2 mg/kg b.w (Plate 8C) which looks like those of control and
caffeine-treated embryos. In combined treatment with caffeine
and retinoic acid doses, missing of the skeleton of the second
row of phalanges was noted (Plate 8E and F) similar to that
observed in 4 mg/kg b.w of retinoic acid-treated embryos. In
the skeleton of the foot, the effect of caffeine and retinoic acid
doses was much obvious. In caffeine-treated embryos and
those treated with retinoic acid, rudimentary phalanges
(Plate 9B –D) as compared to the control (Plate 9A) were
noted. Also, in combined treatments enhancement of the
phalange malformations was found to be dose-dependent of
retinoic acid (Plate 9E and F) in the presence of caffeine.Discussion
The present study did not reveal morphological abnormalities
in either caffeine or retinoic acid in the developing embryos at
14th day of gestation whose mothers’ were administered
caffeine (2 mg/100 g b.w) or those of the mother’s treated with
retinoic acid even at 4 mg/kg b.w dose during the onset of the
second trimester of pregnancy. However, dose-dependent
retinoic acid treatment initiates chondrocyte vacuolation,
depression of PAS+ve intracellular inclusions and depression
of nuclear fluorescence that were concomitant with downregu-
lation of TGFb2 expression in the perichondrium of the devel-
oping vertebrae. Co-administration of caffeine was found to
ameliorate the effects of low (2 mg/kg b.w) rather than the
high dose (4 mg/kg b.w) of retinoic acid. At 18th day of gesta-
tion the uterine horns appeared normal without any signs of
fetoresorption in all treatments. However, the effect of both
caffeine (2 mg/100 g b.w) and retinoic acid at both doses
(2, 4 mg/kg b.w) in Alizarin Red S stain of wholemount
revealed malformed phalanges of the developing limbs either
in separate or in combined treatments. Caffeine is a methylx-
anthine alkaloid present in coffee, tea, and soft drinks and
some drugs excite the central nervous system and have shown
positive actions on the cardiovascular system and in reducing
fatigue. In contrast to our findings, studies indicate that caf-
feine intake may have adverse effects on reproduction and fetal
development including an increase in the risk of premature
delivery, spontaneous abortion and intrauterine growth retar-
dation (Kuczkowski, 2009). Treatment of female mice with
caffeine (60, 120 and 240 mg/kg per day) before and during
pregnancy was found to initiate a series of adverse reproduc-
tive and developmental effects, including delay in the timing
of conception, lower maternal weight gain, placental weight,
lower fetal:placental weight ratio and changes in indices of
fetal growth and development. Similar results, particularly in
terms of placental weight, body weight and intrauterine
growth retardation were seen in rats after caffeine treatment
(20, 60 and 180 mg/kg per day) from gestational day11 to
gestational day 20 (Huang et al., 2012).
Caffeine crosses the placental barrier easily, where it can
directly affect the fetus in several different aspects. The half-
life of caffeine is greatly increased in pregnancy, as it cannot
be metabolized by the fetus or the placenta (Aldridge et al.,
1981). In the first trimester the half life is about ten hours,
while it increases up to 18 h during the third trimester, as the
enzymes in the human liver do not exist until the eight month
of life (Grosso and Bracken, 2005). Several previous studies
focused primarily on the associations between caffeine intake
Plate 5 Photomicrographs of immune-stained sections showing the expression of TGFb2 (arrows) in the perichondrial connective tissue
of control (A), depressed in: caffeine (B), retinoic acid treatments (C, D), combined treatment at 2 mg/kg b w with caffeine (E) and
complete inhibition in combined treatment at 4 mg/kg b w with caffeine (F). Chondrocytes are devoted of the expression in all groups
(stars). immune-stain. Scale bar 20 lm.
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et al., 1982; Martin and Bracken, 1987; Larroque et al., 1993;
Shu et al., 1995; Bech et al., 2007). Based on the dose-
conversion correlation between humans and mice (Wang,
2005), the low dose of caffeine used in the present study
(2 mg/100 g per day for mice is 0.36-fold that of average
caffeine intake during pregnancy in Europe or 0.2-fold that
of average caffeine intake during pregnancy in the US
(Barone and Roberts, 1996). According to a previous study
conducted by Butt and Sultan (2011) a standard cup of coffee
contains, on average, between 100 and 150 mg caffeine; thus,
the aforementioned dose in the present study (2 mg/100 g
daily) of caffeine exposure is equivalent to approximately a
cup of coffee daily consumed in pregnant women. In this con-
text, it has been reported that in women who consume more
than 300 mg caffeine daily, the conception of a primigravida
is reduced by 27% (Bolu´mar et al., 1997). Furthermore, the
risks of spontaneous abortion and low-weight fetuses increase
significantly when the intake of caffeine during pregnancy is
>150 mg/day (Valsamakis et al., 2006). Moreover, as early
as 1980, the US Food and Drug Administration (FDA)
proposed that caffeine should be taken cautiously during preg-
nancy (Fernandes et al., 1998). We showed that caffeine intake
at low dose (2 mg/100 g b.w) per day during pregnancy might
be associated with skeletal related fetal growth characteristicsthat seemed to be most consistently affected from the second
trimester onwards on the basis of TGFb2 downregulation in
the perichondrium as the site of chondrocyte proliferation.
Further follow up studies are needed focused on the effects
of fetal caffeine exposure on postnatal skeletal and bone
measurements.
Furthermore, it is well known that retinoids are essential
for adequate embryo development. They are important signal-
ing molecules for the regulation of cell differentiation, prolifer-
ation and morphogenesis. Inadequate levels of these
compounds (excess or deficiency) results in a set of defects
denoted by retinoic acid embryopathy including neural crest,
limbs and skeleton differentiation (Zile, 1998; Mulder et al.,
2000; Ross et al., 2000; Ali-khan and Hales, 2006; Maden,
2006). Other types of anomalies such as omphalocele,
gastroschisis, limb and rib alterations and tail regression were
noted in pregnant mice in early developmental stages of con-
ception at doses less than 60 mg/kg while doses of 80 mg/kg
or higher provoked many reabsorptions (Quemelo et al.,
2007). In the present study, however, a small dose of retinoic
acid did not initiate such overmentioned teratogenicity.
Dose-dependent alterations of chondrocytes were observed
with concomitant downregulation of TGFb2 expression in
the perichondrium at the 14th day of gestation. These alter-
ations were manifested at 18th day embryos in which a minor
Plate 6 Photographs of uterine horns at E 18 of pregnancy
showing normal horns without embryo resorption in various
treatments similar to control. A (Control), B (caffeine treated), C
(2 mg/kg b.w. retinoic acid-treated), D (4 mg/kg b.w. retinoic acid-
treated), E, F (combined treatment with caffeine and both doses of
retinoic acid, respectively). Scale bar 1 cm.
Plate 7 Photographs of Alizarin Red S-stained foeti at E 18 of
gestation of control (A); caffeine (B); retinoic acid at 2, 4 mg/kg b.
w.. (C, D) and combined with caffeine treatment (E, F) show a
proper skeleton development. Alizarin Red S stain Scale bar 1 cm.
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trans-retinoic acid (RA) effects during embryogenesis,
especially on developing and regenerating limbs in different
vertebrates were recorded in either systemic or locally applied
(Bryant and Gardiner, 1992; Mohanty-Hejmadi et al., 1992;
Maden, 1993), unlike in chickens and amphibians, in which
RA was applied locally to developing or regenerating limbs
or to amputated tails. In mice, RA injections of pregnant
females 4.5–5.5 days after mating were found to be effective
in inducing the duplication effects on lower body including
limbs at higher doses (Quemelo et al., 2007).
Still, however, low dose of retinoic acid treatment of preg-
nant mice, at the onset of organogenesis, is able to provoke
developmental alterations of the skeleton during prenatal life.
Regardless the downregulated expression of TGFb2 as an
inducer of matrix deposition, caffeine co-treatment ameliorates
the intracellular matrix biosynthesis as indicated in PAS-
stained chondrocytes in 2 mg/kg b.w rather than 4 mg/kg b.
w of retinoic acid treatments. In contrast with other reports
for in vitro studies (Tassinari et al., 1991;Tsuang et al., 2006),
caffeine at 50 mg/ kg, increases the osteogenic potential of
osteoblasts, as characterized by increased alkaline phosphatase
activity, collagen synthesis, mineralization of nodules and
expression of osteogenic genes including osteocalcin, osteo-
pontin, sialoprotein, alkaline phosphatase and type I collagen.
Here the most important aspect of our method of caffeine
administration is that the drug was not added to the culture
medium as in most studies; we administered caffeine to moth-
ers during pregnancy, and the drug or its metabolites passed
through the placenta to the fetus. The doses of caffeine used
in this study were chosen based on previously observed effects
on endochondral ossification in the offspring of rats treated
with caffeine (Reis et al., 2014). When added directly to the
culture medium, caffeine inactivates cell survival signaling
and promotes programed cell death by a mitochondria-dependent cascade; cell death thus occurs by apoptosis and
necrosis (Tsuang et al., 2006; Lu et al., 2008). In vitro assay
is thus different from in vivo because the cellular microenviron-
ment of the organism is difficult to reproduce in vitro due to
numerous interdependent intrinsic and extrinsic factors. The
control of proliferation, differentiation and cell maintenance
is carried out by genes, cytokines, developmental and growth
factors and cellular interactions. So, it is difficult to develop
in vitro models that can simulate drug effects in the body
because the drug is metabolized within the mother’s body
Plate 8 Photographs of Alizarin Red S-stained skeleton of hands at E 18 of gestation showing the effect of 4 mg/kg b w retinoic acid on
phalanges deformation (D) as compared to control (A), caffeine treatment (B) and 2 mg/kg b.w. retinoic acid (C) black arrows. Combined
treatment leads to phalanges malformations in both doses of retinoic acid with caffeine (E, F) yellow arrows. Alizarin Red S stain Scale
bar 0.5 cm.
Plate 9 Photographs of Alizarin Red S-stained skeleton of foot at E 18 of gestation showing malformed phalanges in caffeine (B) red
arrow; retinoic acid 2, 4 mg/kg b.w. doses (C, D) white arrows. Dose-dependent malformation of retinoic acid (E, F) yellow arrows in
presence of caffeine compared to control (A) black arrow. Alizarin Red S stain Scale bar 0.5 cm.
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44 F.E.-D.M. Lashein et al.and a small amount may reach to the developing embryo. The
aim of this study was to observe the effects of caffeine in
embryos whose mothers were exposed to caffeine during preg-
nancy, taking into consideration the metabolism of the drug by
the mother and its passage to the fetus through the placenta. In
conclusion, the work presents relatively novel results using
methodology of little use previously and demonstrates the need
for further in vivo studies to better understand the significance
of our results of caffeine and retinoic acid uses during preg-
nancy for their therapeutic importance.
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